ARCHIVES

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves

November 13, 1998

Fisher, NSABP Executive Committee, File Injunction Seeking Herberman’s Removal

August 12, 1994

Cancer Survivors Day Planned or June 5

April 22, 1988

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987